Contact +01 2345 6789 | info@example.com

TB Buzz

KEEP BUZZING

“Marc Beer Secures $42 Million for a Womens Health Startup Through Series B Round and Venture Debt “

Renovia Inc., a women’s health startup co-founded by Marc Beer, is set to move forward the development of several pelvic floor disorder products after Mr. Beer raised $42 million successfully through Series B round as well as venture debt. The Boston-based women’s health startup looks to end pelvic floor disorders through development of diagnostic and therapeutic products. Pelvic floor disorders such as urinary incontinence is a affecting many people around the world. Actually, urinary incontinence affects over 250 million women across the world. The efforts the company is making will improve the lives of women worldwide. Renovia’s first product, Leva device, received FDA approval early last year.

 

The Longwood Fund is a healthcare-focused investor that invested early in Renovia Inc. It joined the Series B round which was conducted by Ascension Ventures and Perceptive Advisors. The funds will go into financing the development and testing of four main therapeutic and diagnostic products including the new generation of the Leva device.

 

In a statement, Marc Beer expressed his gratitude to the leading healthcare investors who decided to support him every step of the way. They all believe in better diagnosing, treating and improving the lives of many women across the world affected by pelvic floor disorders. The Renovia CEO continued to say that the company leverages innovative and proprietary sensor technologies, form factors, and a digital health platform to give their customers valuable data that will inform new treatment options, drive understanding and greater knowledge of pelvic floor disorders. The end result in the long-term will be reduced healthcare costs.

 

Marc Beer has an extensive experience and expertise in the healthcare sector. He is a big and reputable name in the industry. He served as a strategic consultant at OvaScience, a company which announced that it is merging with Millendo Therapeutics.

 

About Marc Beer

 

He brings an extensive experience in biotechnology, devices, diagnostics, pharmaceutics and diagnostics. He has great skills in raising funds as demonstrated by the closing of a significant amount of money in Series A round, Series B round and venture debt. He partnered with Yolanda Lorie and Ramon Iglesias to found Renovia Inc.

 

Mr. Beer was instrumental in the growth of ViaCell, a biotechnology company he founded. He served as CEO of the company and headed its operations in the acquisition, preservation, and development of umbilical blood stem cells up until 2007 when it was acquired by PerkinElmer. He served as a member of the board of directors of Erytech Phara. The renowned entrepreneur also held various positions at Genzyme until he became its Vice President of Global Marketing. He also executed a number of sales and marketing roles in Abbot Laboratories. Marc Beer holds a BS degree from Miami University (Ohio). He holds various positions at Minerva Neurosciences Inc. Learn more: https://people.equilar.com/bio/marc-beer-aegerion-pharmaceuticals-/salary/78453

 

You must be logged in to post a comment.